Clinical Trials Directory

Trials / Terminated

TerminatedNCT02829047

Tolerability, Safety and Efficacy of a New Frequency of Vibrant Capsule Administration

A Prospective, Multicenter, Open-label, Single-arm Study to Assess the Tolerability, Safety and Efficacy of a New Frequency of Vibrant Capsule Administration

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Vibrant Ltd. · Industry
Sex
All
Age
22 Years
Healthy volunteers
Not accepted

Summary

The study is a prospective, multicenter, open-label, single-arm study, to evaluate the tolerability, safety and efficacy of the Vibrant Capsule in relieving constipation.

Detailed description

One arm will be assessed: Vibrant Capsule administered with a sequence of one per day for 2 days, followed by one day without, one per day for 2 days followed by one day without, etc. (14 capsules in 3 weeks). The study will have one interim analysis. Patients will follow a 2 weeks baseline period and then take the Vibrant Capsule for a treatment period of 6 weeks. Data reporting will be done on an electronic Case Report Form and an eDiary. During the 2 weeks of baseline, patients will be asked to refrain from taking any medication or supplement to relieve their constipation. After 14 days the patients will return and eligibility will be re-assessed. Patients will be trained on how to use the base unit. Patients will be instructed to complete a simple patient eDiary each day throughout the duration of the study. After 3 weeks of treatment, the patient will attend for evaluation and to receive new capsules. A final visit will take place at the end of the 6 week treatment period. Patients will receive phone calls up to twice per week and patient compliance will be monitored during the 8 weeks of the study.

Conditions

Interventions

TypeNameDescription
DEVICEVibrating CapsulePatients will receive vibrating capsule for 6 weeks of treatment (14 capsules in 3 weeks)

Timeline

Start date
2016-08-01
Primary completion
2017-03-01
Completion
2017-03-01
First posted
2016-07-12
Last updated
2024-06-14
Results posted
2024-06-14

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02829047. Inclusion in this directory is not an endorsement.